| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |